, and this value correlates with the transvalvular gradients (8). AVR decreases GI bleeding in 93% of patients with angiodysplasia, whereas GI surgery produces a durable remission in as few as 5% of the patients (9).
. It has been shown that 20% to 70% of AS patients have a marked reduction in the percentage of vWF HMWM (7, 8) , and this value correlates with the transvalvular gradients (8) . AVR decreases GI bleeding in 93% of patients with angiodysplasia, whereas GI surgery produces a durable remission in as few as 5% of the patients (9).
In the transcutaneous aortic valve intervention (TAVI) cohort, 9.2% of elderly patients unfit for AVR had a history of GI bleeding or anemia, including 6% with GI bleeding unrelated to angiodysplasia, 1.5% with bleeding from undefined origin, and 1.7% with documented HS (10) . HS was reported to increase the periprocedural bleeding risk during TAVI, which is an effective therapeutic option in the setting of GI bleeding, with severe transfusion-dependent anemia observed only for the patient in whom TAVI failed edu.pl.
